Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-27

Clinical Trial Update: Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 multicohort trial evaluating trabectedin with low-dose radiation therapy in advanced/metastatic soft tissue sarcomas and related bone tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trabectedin (trabectedin)

Snippet

Sponsor: Grupo Espanol de Investigacion en Sarcomas | Conditions: Soft Tissue Sarcoma, Bone Tumors | Phase 2 | Status: UNKNOWN